Last 12 months
Inside the activity.
8 purchase rows · 122 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 3 | 8 |
| Apr 2026 | 0 | 44 |
| May 2026 | 2 | 16 |
| Jun 2026 | 2 | 24 |
| Jul 2026 | 0 | 12 |
| Aug 2026 | 0 | 10 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 1 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 06, 2024 Filed Sep 10, 2024 20:05 UTC |
Scalzo Richard WilliamSVP, Head of Finance & Admin.
|
SaleCommon Stock | 1,700 | $32.63 | $55,471.00 |
DisclosureSEC source: 0000950170-24-105123 · ownership.xml · nonDerivative · entry 9 Scalzo Richard William · CIK 0001789545 · SVP, Head of Finance & Admin. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,426 F1 · balance_after: Includes 101,426 unvested RSUs. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 20:05 UTC |
Scalzo Richard WilliamSVP, Head of Finance & Admin.
|
SaleCommon Stock | 124,374 | $32.14 | $3,997,380.36 |
DisclosureSEC source: 0000950170-24-105123 · ownership.xml · nonDerivative · entry 8 Scalzo Richard William · CIK 0001789545 · SVP, Head of Finance & Admin. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,126 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $31.62 to $32.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4. F1 · balance_after: Includes 101,426 unvested RSUs. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 20:05 UTC |
Scalzo Richard WilliamSVP, Head of Finance & Admin.
|
Exercise / conversionCommon Stock | 6,552 | $10.88 | $71,285.76 |
DisclosureSEC source: 0000950170-24-105123 · ownership.xml · nonDerivative · entry 7 Scalzo Richard William · CIK 0001789545 · SVP, Head of Finance & Admin. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 227,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 101,426 unvested RSUs. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 20:05 UTC |
Scalzo Richard WilliamSVP, Head of Finance & Admin.
|
Exercise / conversionCommon Stock | 18,750 | $10.72 | $201,000.00 |
DisclosureSEC source: 0000950170-24-105123 · ownership.xml · nonDerivative · entry 6 Scalzo Richard William · CIK 0001789545 · SVP, Head of Finance & Admin. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 220,948 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 101,426 unvested RSUs. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 20:05 UTC |
Scalzo Richard WilliamSVP, Head of Finance & Admin.
|
Exercise / conversionCommon Stock | 29,792 | $8.58 | $255,615.36 |
DisclosureSEC source: 0000950170-24-105123 · ownership.xml · nonDerivative · entry 5 Scalzo Richard William · CIK 0001789545 · SVP, Head of Finance & Admin. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 202,198 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 101,426 unvested RSUs. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 20:05 UTC |
Scalzo Richard WilliamSVP, Head of Finance & Admin.
|
Exercise / conversionCommon Stock | 16,696 | $13.12 | $219,051.52 |
DisclosureSEC source: 0000950170-24-105123 · ownership.xml · nonDerivative · entry 4 Scalzo Richard William · CIK 0001789545 · SVP, Head of Finance & Admin. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,406 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 101,426 unvested RSUs. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 20:05 UTC |
Scalzo Richard WilliamSVP, Head of Finance & Admin.
|
Exercise / conversionCommon Stock | 34,833 | $19.00 | $661,827.00 |
DisclosureSEC source: 0000950170-24-105123 · ownership.xml · nonDerivative · entry 3 Scalzo Richard William · CIK 0001789545 · SVP, Head of Finance & Admin. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,710 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 101,426 unvested RSUs. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 20:05 UTC |
Scalzo Richard WilliamSVP, Head of Finance & Admin.
|
Exercise / conversionCommon Stock | 3,353 | $5.54 | $18,575.62 |
DisclosureSEC source: 0000950170-24-105123 · ownership.xml · nonDerivative · entry 2 Scalzo Richard William · CIK 0001789545 · SVP, Head of Finance & Admin. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,877 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 101,426 unvested RSUs. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 20:05 UTC |
Scalzo Richard WilliamSVP, Head of Finance & Admin.
|
Exercise / conversionCommon Stock | 6,502 | $5.54 | $36,021.08 |
DisclosureSEC source: 0000950170-24-105123 · ownership.xml · nonDerivative · entry 1 Scalzo Richard William · CIK 0001789545 · SVP, Head of Finance & Admin. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,524 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 101,426 unvested RSUs. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:05 UTC |
Kersten DirkDirector
|
SaleCommon Stock | 1,577 | $35.03 | $55,242.31 |
DisclosureSEC source: 0000950170-24-104738 · ownership.xml · nonDerivative · entry 1 Kersten Dirk · CIK 0001823682 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 398,423 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Forbion Capital Fund IV Cooperatief U.A. ("FCF IV") on April 9, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $35.00 to $35.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3 · ownership.nature: The shares are held directly by FCF IV. Forbion IV Management B.V. ("Forbion Management"), the director of FCF IV, may be deemed to have voting and dispositive power over the shares held by FCF IV. Investment decisions with respect to the shares held by FCF IV can be made by FCPM III Services B.V., the director of Forbion Management, which may delegate such powers to its investment committee which may delegate such powers to the authorized representatives of Forbion Management. Messrs. Slootweg, van Osch, Mulder, van Houten, Reithinger and Boorsma (the "Partners") are partners of FCPM III Services B.V., which acts as the investment advisor to the directors of FCF IV. The Reporting Person is a partner of Forbion Management and a member of the investment committee of Forbion Management. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein. Read SEC document |
| September 04, 2024 Filed Sep 4, 2024 21:42 UTC |
Cox JohnDirector · CEO & President
|
PurchaseCommon Stock | 7,200 | $33.09 | $238,248.00 |
DisclosureSEC source: 0000950170-24-103533 · ownership.xml · nonDerivative · entry 8 Cox John · CIK 0001498428 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust #4 Disclosed balance after: 8,000 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices within the range of $32.60 to $33.58, inclusive. F2 · ownership.nature: These shares are held in a trust for the benefit of a child of the Reporting Person. Read SEC document |
| September 04, 2024 Filed Sep 4, 2024 21:42 UTC |
Cox JohnDirector · CEO & President
|
PurchaseCommon Stock | 800 | $32.57 | $26,056.00 |
DisclosureSEC source: 0000950170-24-103533 · ownership.xml · nonDerivative · entry 7 Cox John · CIK 0001498428 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust #4 Disclosed balance after: 800 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices within the range of $32.55 to $32.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in the footnotes of this Form 4. F2 · ownership.nature: These shares are held in a trust for the benefit of a child of the Reporting Person. Read SEC document |
| September 04, 2024 Filed Sep 4, 2024 21:42 UTC |
Cox JohnDirector · CEO & President
|
PurchaseCommon Stock | 7,200 | $33.09 | $238,248.00 |
DisclosureSEC source: 0000950170-24-103533 · ownership.xml · nonDerivative · entry 6 Cox John · CIK 0001498428 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust #3 Disclosed balance after: 8,000 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices within the range of $32.60 to $33.58, inclusive. F2 · ownership.nature: These shares are held in a trust for the benefit of a child of the Reporting Person. Read SEC document |
| September 04, 2024 Filed Sep 4, 2024 21:42 UTC |
Cox JohnDirector · CEO & President
|
PurchaseCommon Stock | 800 | $32.57 | $26,056.00 |
DisclosureSEC source: 0000950170-24-103533 · ownership.xml · nonDerivative · entry 5 Cox John · CIK 0001498428 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust #3 Disclosed balance after: 800 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices within the range of $32.55 to $32.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in the footnotes of this Form 4. F2 · ownership.nature: These shares are held in a trust for the benefit of a child of the Reporting Person. Read SEC document |
| September 04, 2024 Filed Sep 4, 2024 21:42 UTC |
Cox JohnDirector · CEO & President
|
PurchaseCommon Stock | 7,200 | $33.09 | $238,248.00 |
DisclosureSEC source: 0000950170-24-103533 · ownership.xml · nonDerivative · entry 4 Cox John · CIK 0001498428 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust #2 Disclosed balance after: 8,000 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices within the range of $32.60 to $33.58, inclusive. F2 · ownership.nature: These shares are held in a trust for the benefit of a child of the Reporting Person. Read SEC document |
| September 04, 2024 Filed Sep 4, 2024 21:42 UTC |
Cox JohnDirector · CEO & President
|
PurchaseCommon Stock | 800 | $32.57 | $26,056.00 |
DisclosureSEC source: 0000950170-24-103533 · ownership.xml · nonDerivative · entry 3 Cox John · CIK 0001498428 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust #2 Disclosed balance after: 800 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices within the range of $32.55 to $32.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in the footnotes of this Form 4. F2 · ownership.nature: These shares are held in a trust for the benefit of a child of the Reporting Person. Read SEC document |
| September 04, 2024 Filed Sep 4, 2024 21:42 UTC |
Cox JohnDirector · CEO & President
|
PurchaseCommon Stock | 7,200 | $33.09 | $238,248.00 |
DisclosureSEC source: 0000950170-24-103533 · ownership.xml · nonDerivative · entry 2 Cox John · CIK 0001498428 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust #1 Disclosed balance after: 8,000 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices within the range of $32.60 to $33.58, inclusive. F2 · ownership.nature: These shares are held in a trust for the benefit of a child of the Reporting Person. Read SEC document |
| September 04, 2024 Filed Sep 4, 2024 21:42 UTC |
Cox JohnDirector · CEO & President
|
PurchaseCommon Stock | 800 | $32.57 | $26,056.00 |
DisclosureSEC source: 0000950170-24-103533 · ownership.xml · nonDerivative · entry 1 Cox John · CIK 0001498428 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust #1 Disclosed balance after: 800 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices within the range of $32.55 to $32.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in the footnotes of this Form 4. F2 · ownership.nature: These shares are held in a trust for the benefit of a child of the Reporting Person. Read SEC document |
| September 03, 2024 Filed Sep 3, 2024 22:16 UTC |
Friedl-Naderer JohannaChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 185,300 | $0.00 Strike: $31.94 | $0.00 |
DisclosureSEC source: 0000950170-24-103033 · ownership.xml · derivative · entry 2 Friedl-Naderer Johanna · CIK 0001915598 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,300 Underlying: Common Stock · 185,300 shares Expires 2034-09-02 F2 · derivative.exercise_date: This option was granted on September 3, 2024. The shares underlying the option are scheduled to vest over four years, with 25% of the shares vesting on September 3, 2025, and the remainder vesting in equal quarterly installments thereafter, subject to continuous service. Read SEC document |
| September 03, 2024 Filed Sep 3, 2024 22:16 UTC |
Friedl-Naderer JohannaChief Commercial Officer
|
GrantCommon Stock | 58,400 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-103033 · ownership.xml · nonDerivative · entry 1 Friedl-Naderer Johanna · CIK 0001915598 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,400 F1 · shares: Consists of shares of Common Stock issuable under 58,400 restricted stock units ("RSU"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal annual installments over four years with the first installment vesting on September 3, 2025. Read SEC document |
| September 03, 2024 Filed Sep 3, 2024 22:22 UTC |
Kerr DouglasChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 150,300 | $0.00 Strike: $31.94 | $0.00 |
DisclosureSEC source: 0000950170-24-103037 · ownership.xml · derivative · entry 2 Kerr Douglas · CIK 0001814189 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,300 Underlying: Common Stock · 150,300 shares Expires 2034-09-02 F2 · derivative.exercise_date: This option was granted on September 3, 2024. The shares underlying the option are scheduled to vest over four years, with 25% of the shares vesting on September 3, 2025, and the remainder vesting in equal quarterly installments thereafter, subject to continuous service. Read SEC document |
| September 03, 2024 Filed Sep 3, 2024 22:22 UTC |
Kerr DouglasChief Medical Officer
|
GrantCommon Stock | 47,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-103037 · ownership.xml · nonDerivative · entry 1 Kerr Douglas · CIK 0001814189 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,500 F1 · shares: Consists of shares of Common Stock issuable under 47,500 restricted stock units ("RSU"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal annual installments over four years with the first installment vesting on September 3, 2025. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 20:05 UTC |
Kersten DirkDirector
|
SaleCommon Stock | 6,204 | $46.01 | $285,446.04 |
DisclosureSEC source: 0000950170-24-103382 · ownership.xml · nonDerivative · entry 2 Kersten Dirk · CIK 0001823682 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 400,000 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Forbion Capital Fund IV Cooperatief U.A. ("FCF IV") on April 9, 2024. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $45.89 to $46.26, inclusive. F3 · ownership.nature: The shares are held directly by FCF IV. Forbion IV Management B.V. ("Forbion Management"), the director of FCF IV, may be deemed to have voting and dispositive power over the shares held by FCF IV. Investment decisions with respect to the shares held by FCF IV can be made by FCPM III Services B.V., the director of Forbion Management, which may delegate such powers to its investment committee which may delegate such powers to the authorized representatives of Forbion Management. Messrs. Slootweg, van Osch, Mulder, van Houten, Reithinger and Boorsma (the "Partners") are partners of FCPM III Services B.V., which acts as the investment advisor to the directors of FCF IV. The Reporting Person is a partner of Forbion Management and a member of the investment committee of Forbion Management. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 20:05 UTC |
Kersten DirkDirector
|
SaleCommon Stock | 25,096 | $45.49 | $1,141,617.04 |
DisclosureSEC source: 0000950170-24-103382 · ownership.xml · nonDerivative · entry 1 Kersten Dirk · CIK 0001823682 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 406,204 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Forbion Capital Fund IV Cooperatief U.A. ("FCF IV") on April 9, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $44.885 to $45.865, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in the footnotes of this Form 4. F3 · ownership.nature: The shares are held directly by FCF IV. Forbion IV Management B.V. ("Forbion Management"), the director of FCF IV, may be deemed to have voting and dispositive power over the shares held by FCF IV. Investment decisions with respect to the shares held by FCF IV can be made by FCPM III Services B.V., the director of Forbion Management, which may delegate such powers to its investment committee which may delegate such powers to the authorized representatives of Forbion Management. Messrs. Slootweg, van Osch, Mulder, van Houten, Reithinger and Boorsma (the "Partners") are partners of FCPM III Services B.V., which acts as the investment advisor to the directors of FCF IV. The Reporting Person is a partner of Forbion Management and a member of the investment committee of Forbion Management. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein. Read SEC document |
| August 29, 2024 Filed Aug 30, 2024 20:05 UTC |
Kersten DirkDirector
|
SaleCommon Stock | 10,768 | $45.81 | $493,282.08 |
DisclosureSEC source: 0000950170-24-102326 · ownership.xml · nonDerivative · entry 4 Kersten Dirk · CIK 0001823682 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 431,300 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Forbion Capital Fund IV Cooperatief U.A. ("FCF IV") on April 9, 2024. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $45.66 to $46.03, inclusive. F3 · ownership.nature: The shares are held directly by FCF IV. Forbion IV Management B.V. ("Forbion Management"), the director of FCF IV, may be deemed to have voting and dispositive power over the shares held by FCF IV. Investment decisions with respect to the shares held by FCF IV can be made by FCPM III Services B.V., the director of Forbion Management, which may delegate such powers to its investment committee which may delegate such powers to the authorized representatives of Forbion Management. Messrs. Slootweg, van Osch, Mulder, van Houten, Reithinger and Boorsma (the "Partners") are partners of FCPM III Services B.V., which acts as the investment advisor to the directors of FCF IV. The Reporting Person is a partner of Forbion Management and a member of the investment committee of Forbion Management. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein. Read SEC document |
| August 29, 2024 Filed Aug 30, 2024 20:05 UTC |
Kersten DirkDirector
|
SaleCommon Stock | 45,640 | $45.19 | $2,062,471.60 |
DisclosureSEC source: 0000950170-24-102326 · ownership.xml · nonDerivative · entry 3 Kersten Dirk · CIK 0001823682 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 442,068 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Forbion Capital Fund IV Cooperatief U.A. ("FCF IV") on April 9, 2024. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $44.65 to $45.63, inclusive. F3 · ownership.nature: The shares are held directly by FCF IV. Forbion IV Management B.V. ("Forbion Management"), the director of FCF IV, may be deemed to have voting and dispositive power over the shares held by FCF IV. Investment decisions with respect to the shares held by FCF IV can be made by FCPM III Services B.V., the director of Forbion Management, which may delegate such powers to its investment committee which may delegate such powers to the authorized representatives of Forbion Management. Messrs. Slootweg, van Osch, Mulder, van Houten, Reithinger and Boorsma (the "Partners") are partners of FCPM III Services B.V., which acts as the investment advisor to the directors of FCF IV. The Reporting Person is a partner of Forbion Management and a member of the investment committee of Forbion Management. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein. Read SEC document |
| August 28, 2024 Filed Aug 30, 2024 20:05 UTC |
Kersten DirkDirector
|
SaleCommon Stock | 61,467 | $44.94 | $2,762,326.98 |
DisclosureSEC source: 0000950170-24-102326 · ownership.xml · nonDerivative · entry 2 Kersten Dirk · CIK 0001823682 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 487,708 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Forbion Capital Fund IV Cooperatief U.A. ("FCF IV") on April 9, 2024. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $44.76 to $45.11, inclusive. F3 · ownership.nature: The shares are held directly by FCF IV. Forbion IV Management B.V. ("Forbion Management"), the director of FCF IV, may be deemed to have voting and dispositive power over the shares held by FCF IV. Investment decisions with respect to the shares held by FCF IV can be made by FCPM III Services B.V., the director of Forbion Management, which may delegate such powers to its investment committee which may delegate such powers to the authorized representatives of Forbion Management. Messrs. Slootweg, van Osch, Mulder, van Houten, Reithinger and Boorsma (the "Partners") are partners of FCPM III Services B.V., which acts as the investment advisor to the directors of FCF IV. The Reporting Person is a partner of Forbion Management and a member of the investment committee of Forbion Management. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein. Read SEC document |
| August 28, 2024 Filed Aug 30, 2024 20:05 UTC |
Kersten DirkDirector
|
SaleCommon Stock | 16,386 | $44.41 | $727,702.26 |
DisclosureSEC source: 0000950170-24-102326 · ownership.xml · nonDerivative · entry 1 Kersten Dirk · CIK 0001823682 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 549,175 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Forbion Capital Fund IV Cooperatief U.A. ("FCF IV") on April 9, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $43.76 to $44.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in the footnotes of this Form 4. F3 · ownership.nature: The shares are held directly by FCF IV. Forbion IV Management B.V. ("Forbion Management"), the director of FCF IV, may be deemed to have voting and dispositive power over the shares held by FCF IV. Investment decisions with respect to the shares held by FCF IV can be made by FCPM III Services B.V., the director of Forbion Management, which may delegate such powers to its investment committee which may delegate such powers to the authorized representatives of Forbion Management. Messrs. Slootweg, van Osch, Mulder, van Houten, Reithinger and Boorsma (the "Partners") are partners of FCPM III Services B.V., which acts as the investment advisor to the directors of FCF IV. The Reporting Person is a partner of Forbion Management and a member of the investment committee of Forbion Management. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein. Read SEC document |
| August 27, 2024 Filed Aug 28, 2024 20:05 UTC |
Kersten DirkDirector
|
SaleCommon Stock | 65,403 | $44.28 | $2,896,044.84 |
DisclosureSEC source: 0000950170-24-101378 · ownership.xml · nonDerivative · entry 3 Kersten Dirk · CIK 0001823682 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 565,561 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Forbion Capital Fund IV Cooperatief U.A. ("FCF IV") on April 9, 2024. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $43.79 to $44.67, inclusive. F3 · ownership.nature: The shares are held directly by FCF IV. Forbion IV Management B.V. ("Forbion Management"), the director of FCF IV, may be deemed to have voting and dispositive power over the shares held by FCF IV. Investment decisions with respect to the shares held by FCF IV can be made by FCPM III Services B.V., the director of Forbion Management, which may delegate such powers to its investment committee which may delegate such powers to the authorized representatives of Forbion Management. Messrs. Slootweg, van Osch, Mulder, van Houten, Reithinger and Boorsma (the "Partners") are partners of FCPM III Services B.V., which acts as the investment advisor to the directors of FCF IV. The Reporting Person is a partner of Forbion Management and a member of the investment committee of Forbion Management. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein. Read SEC document |
| August 26, 2024 Filed Aug 28, 2024 20:05 UTC |
Kersten DirkDirector
|
SaleCommon Stock | 11,534 | $45.79 | $528,141.86 |
DisclosureSEC source: 0000950170-24-101378 · ownership.xml · nonDerivative · entry 2 Kersten Dirk · CIK 0001823682 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 630,964 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Forbion Capital Fund IV Cooperatief U.A. ("FCF IV") on April 9, 2024. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $45.71 to $46.16, inclusive. F3 · ownership.nature: The shares are held directly by FCF IV. Forbion IV Management B.V. ("Forbion Management"), the director of FCF IV, may be deemed to have voting and dispositive power over the shares held by FCF IV. Investment decisions with respect to the shares held by FCF IV can be made by FCPM III Services B.V., the director of Forbion Management, which may delegate such powers to its investment committee which may delegate such powers to the authorized representatives of Forbion Management. Messrs. Slootweg, van Osch, Mulder, van Houten, Reithinger and Boorsma (the "Partners") are partners of FCPM III Services B.V., which acts as the investment advisor to the directors of FCF IV. The Reporting Person is a partner of Forbion Management and a member of the investment committee of Forbion Management. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein. Read SEC document |
| August 26, 2024 Filed Aug 28, 2024 20:05 UTC |
Kersten DirkDirector
|
SaleCommon Stock | 77,963 | $45.23 | $3,526,266.49 |
DisclosureSEC source: 0000950170-24-101378 · ownership.xml · nonDerivative · entry 1 Kersten Dirk · CIK 0001823682 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 642,498 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Forbion Capital Fund IV Cooperatief U.A. ("FCF IV") on April 9, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $44.71 to $45.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in the footnotes of this Form 4. F3 · ownership.nature: The shares are held directly by FCF IV. Forbion IV Management B.V. ("Forbion Management"), the director of FCF IV, may be deemed to have voting and dispositive power over the shares held by FCF IV. Investment decisions with respect to the shares held by FCF IV can be made by FCPM III Services B.V., the director of Forbion Management, which may delegate such powers to its investment committee which may delegate such powers to the authorized representatives of Forbion Management. Messrs. Slootweg, van Osch, Mulder, van Houten, Reithinger and Boorsma (the "Partners") are partners of FCPM III Services B.V., which acts as the investment advisor to the directors of FCF IV. The Reporting Person is a partner of Forbion Management and a member of the investment committee of Forbion Management. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein. Read SEC document |
| August 23, 2024 Filed Aug 26, 2024 20:05 UTC |
Kersten DirkDirector
|
SaleCommon Stock | 64,133 | $46.37 | $2,973,847.21 |
DisclosureSEC source: 0000950170-24-100532 · ownership.xml · nonDerivative · entry 4 Kersten Dirk · CIK 0001823682 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 720,461 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Forbion Capital Fund IV Cooperatief U.A. ("FCF IV") on April 9, 2024. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $46.14 to $46.76, inclusive. F3 · ownership.nature: The shares are held directly by FCF IV. Forbion IV Management B.V. ("Forbion Management"), the director of FCF IV, may be deemed to have voting and dispositive power over the shares held by FCF IV. Investment decisions with respect to the shares held by FCF IV can be made by FCPM III Services B.V., the director of Forbion Management, which may delegate such powers to its investment committee which may delegate such powers to the authorized representatives of Forbion Management. Messrs. Slootweg, van Osch, Mulder, van Houten, Reithinger and Boorsma (the "Partners") are partners of FCPM III Services B.V., which acts as the investment advisor to the directors of FCF IV. The Reporting Person is a partner of Forbion Management and a member of the investment committee of Forbion Management. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein. Read SEC document |
| August 23, 2024 Filed Aug 26, 2024 20:05 UTC |
Kersten DirkDirector
|
SaleCommon Stock | 20,955 | $45.82 | $960,158.10 |
DisclosureSEC source: 0000950170-24-100532 · ownership.xml · nonDerivative · entry 3 Kersten Dirk · CIK 0001823682 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 784,594 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Forbion Capital Fund IV Cooperatief U.A. ("FCF IV") on April 9, 2024. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $45.14 to $46.13, inclusive. F3 · ownership.nature: The shares are held directly by FCF IV. Forbion IV Management B.V. ("Forbion Management"), the director of FCF IV, may be deemed to have voting and dispositive power over the shares held by FCF IV. Investment decisions with respect to the shares held by FCF IV can be made by FCPM III Services B.V., the director of Forbion Management, which may delegate such powers to its investment committee which may delegate such powers to the authorized representatives of Forbion Management. Messrs. Slootweg, van Osch, Mulder, van Houten, Reithinger and Boorsma (the "Partners") are partners of FCPM III Services B.V., which acts as the investment advisor to the directors of FCF IV. The Reporting Person is a partner of Forbion Management and a member of the investment committee of Forbion Management. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein. Read SEC document |
| August 22, 2024 Filed Aug 26, 2024 20:05 UTC |
Kersten DirkDirector
|
SaleCommon Stock | 413 | $46.97 | $19,398.61 |
DisclosureSEC source: 0000950170-24-100532 · ownership.xml · nonDerivative · entry 2 Kersten Dirk · CIK 0001823682 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 805,549 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Forbion Capital Fund IV Cooperatief U.A. ("FCF IV") on April 9, 2024. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $46.76 to $47.06, inclusive. F3 · ownership.nature: The shares are held directly by FCF IV. Forbion IV Management B.V. ("Forbion Management"), the director of FCF IV, may be deemed to have voting and dispositive power over the shares held by FCF IV. Investment decisions with respect to the shares held by FCF IV can be made by FCPM III Services B.V., the director of Forbion Management, which may delegate such powers to its investment committee which may delegate such powers to the authorized representatives of Forbion Management. Messrs. Slootweg, van Osch, Mulder, van Houten, Reithinger and Boorsma (the "Partners") are partners of FCPM III Services B.V., which acts as the investment advisor to the directors of FCF IV. The Reporting Person is a partner of Forbion Management and a member of the investment committee of Forbion Management. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein. Read SEC document |
| August 22, 2024 Filed Aug 26, 2024 20:05 UTC |
Kersten DirkDirector
|
SaleCommon Stock | 94,908 | $45.82 | $4,348,684.56 |
DisclosureSEC source: 0000950170-24-100532 · ownership.xml · nonDerivative · entry 1 Kersten Dirk · CIK 0001823682 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 805,962 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Forbion Capital Fund IV Cooperatief U.A. ("FCF IV") on April 9, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $45.45 to $46.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in the footnotes of this Form 4. F3 · ownership.nature: The shares are held directly by FCF IV. Forbion IV Management B.V. ("Forbion Management"), the director of FCF IV, may be deemed to have voting and dispositive power over the shares held by FCF IV. Investment decisions with respect to the shares held by FCF IV can be made by FCPM III Services B.V., the director of Forbion Management, which may delegate such powers to its investment committee which may delegate such powers to the authorized representatives of Forbion Management. Messrs. Slootweg, van Osch, Mulder, van Houten, Reithinger and Boorsma (the "Partners") are partners of FCPM III Services B.V., which acts as the investment advisor to the directors of FCF IV. The Reporting Person is a partner of Forbion Management and a member of the investment committee of Forbion Management. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein. Read SEC document |
| August 21, 2024 Filed Aug 22, 2024 20:05 UTC |
Kersten DirkDirector
|
SaleCommon Stock | 71,245 | $47.01 | $3,349,227.45 |
DisclosureSEC source: 0000950170-24-099831 · ownership.xml · nonDerivative · entry 5 Kersten Dirk · CIK 0001823682 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 900,870 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Forbion Capital Fund IV Cooperatief U.A. ("FCF IV") on April 9, 2024. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $46.86 to $47.34, inclusive. F3 · ownership.nature: The shares are held directly by FCF IV. Forbion IV Management B.V. ("Forbion Management"), the director of FCF IV, may be deemed to have voting and dispositive power over the shares held by FCF IV. Investment decisions with respect to the shares held by FCF IV can be made by FCPM III Services B.V., the director of Forbion Management, which may delegate such powers to its investment committee which may delegate such powers to the authorized representatives of Forbion Management. Messrs. Slootweg, van Osch, Mulder, van Houten, Reithinger and Boorsma (the "Partners") are partners of FCPM III Services B.V., which acts as the investment advisor to the directors of FCF IV. The Reporting Person is a partner of Forbion Management and a member of the investment committee of Forbion Management. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein. Read SEC document |
| August 21, 2024 Filed Aug 22, 2024 20:05 UTC |
Kersten DirkDirector
|
SaleCommon Stock | 64,518 | $46.52 | $3,001,377.36 |
DisclosureSEC source: 0000950170-24-099831 · ownership.xml · nonDerivative · entry 4 Kersten Dirk · CIK 0001823682 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 972,115 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Forbion Capital Fund IV Cooperatief U.A. ("FCF IV") on April 9, 2024. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $45.86 to $46.85, inclusive. F3 · ownership.nature: The shares are held directly by FCF IV. Forbion IV Management B.V. ("Forbion Management"), the director of FCF IV, may be deemed to have voting and dispositive power over the shares held by FCF IV. Investment decisions with respect to the shares held by FCF IV can be made by FCPM III Services B.V., the director of Forbion Management, which may delegate such powers to its investment committee which may delegate such powers to the authorized representatives of Forbion Management. Messrs. Slootweg, van Osch, Mulder, van Houten, Reithinger and Boorsma (the "Partners") are partners of FCPM III Services B.V., which acts as the investment advisor to the directors of FCF IV. The Reporting Person is a partner of Forbion Management and a member of the investment committee of Forbion Management. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein. Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 20:05 UTC |
Kersten DirkDirector
|
SaleCommon Stock | 8,326 | $47.30 | $393,819.80 |
DisclosureSEC source: 0000950170-24-099831 · ownership.xml · nonDerivative · entry 3 Kersten Dirk · CIK 0001823682 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 1,036,633 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Forbion Capital Fund IV Cooperatief U.A. ("FCF IV") on April 9, 2024. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $47.25 to $47.38, inclusive. F3 · ownership.nature: The shares are held directly by FCF IV. Forbion IV Management B.V. ("Forbion Management"), the director of FCF IV, may be deemed to have voting and dispositive power over the shares held by FCF IV. Investment decisions with respect to the shares held by FCF IV can be made by FCPM III Services B.V., the director of Forbion Management, which may delegate such powers to its investment committee which may delegate such powers to the authorized representatives of Forbion Management. Messrs. Slootweg, van Osch, Mulder, van Houten, Reithinger and Boorsma (the "Partners") are partners of FCPM III Services B.V., which acts as the investment advisor to the directors of FCF IV. The Reporting Person is a partner of Forbion Management and a member of the investment committee of Forbion Management. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein. Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 20:05 UTC |
Kersten DirkDirector
|
SaleCommon Stock | 35,457 | $46.94 | $1,664,351.58 |
DisclosureSEC source: 0000950170-24-099831 · ownership.xml · nonDerivative · entry 2 Kersten Dirk · CIK 0001823682 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 1,044,959 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Forbion Capital Fund IV Cooperatief U.A. ("FCF IV") on April 9, 2024. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $46.25 to $47.24, inclusive. F3 · ownership.nature: The shares are held directly by FCF IV. Forbion IV Management B.V. ("Forbion Management"), the director of FCF IV, may be deemed to have voting and dispositive power over the shares held by FCF IV. Investment decisions with respect to the shares held by FCF IV can be made by FCPM III Services B.V., the director of Forbion Management, which may delegate such powers to its investment committee which may delegate such powers to the authorized representatives of Forbion Management. Messrs. Slootweg, van Osch, Mulder, van Houten, Reithinger and Boorsma (the "Partners") are partners of FCPM III Services B.V., which acts as the investment advisor to the directors of FCF IV. The Reporting Person is a partner of Forbion Management and a member of the investment committee of Forbion Management. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein. Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 20:05 UTC |
Kersten DirkDirector
|
SaleCommon Stock | 43,057 | $45.68 | $1,966,843.76 |
DisclosureSEC source: 0000950170-24-099831 · ownership.xml · nonDerivative · entry 1 Kersten Dirk · CIK 0001823682 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 1,080,416 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Forbion Capital Fund IV Cooperatief U.A. ("FCF IV") on April 9, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $45.21 to $46.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in the footnotes of this Form 4. F3 · ownership.nature: The shares are held directly by FCF IV. Forbion IV Management B.V. ("Forbion Management"), the director of FCF IV, may be deemed to have voting and dispositive power over the shares held by FCF IV. Investment decisions with respect to the shares held by FCF IV can be made by FCPM III Services B.V., the director of Forbion Management, which may delegate such powers to its investment committee which may delegate such powers to the authorized representatives of Forbion Management. Messrs. Slootweg, van Osch, Mulder, van Houten, Reithinger and Boorsma (the "Partners") are partners of FCPM III Services B.V., which acts as the investment advisor to the directors of FCF IV. The Reporting Person is a partner of Forbion Management and a member of the investment committee of Forbion Management. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein. Read SEC document |
| August 19, 2024 Filed Aug 20, 2024 16:26 UTC |
Beskrovnaya OxanaChief Scientific Officer
|
SaleCommon Stock | 296 | $46.00 | $13,616.00 |
DisclosureSEC source: 0000950170-24-099122 · ownership.xml · nonDerivative · entry 2 Beskrovnaya Oxana · CIK 0001824542 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 144,875 F1 · kind: Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on November 15, 2023. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 that was entered into on January 25, 2024 and the sale does not represent a discretionary trade by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $45.53 to $46.45, inclusive. F4 · balance_after: Includes 119,668 unvested RSUs. Read SEC document |
| August 19, 2024 Filed Aug 20, 2024 16:26 UTC |
Beskrovnaya OxanaChief Scientific Officer
|
SaleCommon Stock | 2,340 | $45.01 | $105,323.40 |
DisclosureSEC source: 0000950170-24-099122 · ownership.xml · nonDerivative · entry 1 Beskrovnaya Oxana · CIK 0001824542 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 145,171 F1 · kind: Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on November 15, 2023. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 that was entered into on January 25, 2024 and the sale does not represent a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $44.51 to $45.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes of this Form 4. Read SEC document |
| August 19, 2024 Filed Aug 20, 2024 20:28 UTC |
Scalzo Richard WilliamSVP, Head of Finance & Admin.
|
SaleCommon Stock | 310 | $46.00 | $14,260.00 |
DisclosureSEC source: 0000950170-24-099128 · ownership.xml · nonDerivative · entry 2 Scalzo Richard William · CIK 0001789545 · SVP, Head of Finance & Admin. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 111,022 F1 · kind: Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on November 15, 2023. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 that was entered into on January 25, 2024 and the sale does not represent a discretionary trade by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $45.53 to $46.45, inclusive. Read SEC document |
| August 19, 2024 Filed Aug 20, 2024 20:28 UTC |
Scalzo Richard WilliamSVP, Head of Finance & Admin.
|
SaleCommon Stock | 2,442 | $45.01 | $109,914.42 |
DisclosureSEC source: 0000950170-24-099128 · ownership.xml · nonDerivative · entry 1 Scalzo Richard William · CIK 0001789545 · SVP, Head of Finance & Admin. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 111,332 F1 · kind: Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on November 15, 2023. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 that was entered into on January 25, 2024 and the sale does not represent a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $44.51 to $45.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes of this Form 4. F3 · balance_after: Includes 101,426 unvested RSUs. Read SEC document |
| August 19, 2024 Filed Aug 20, 2024 20:27 UTC |
McNeill JonathanChief Business Officer
|
SaleCommon Stock | 305 | $46.00 | $14,030.00 |
DisclosureSEC source: 0000950170-24-099127 · ownership.xml · nonDerivative · entry 2 McNeill Jonathan · CIK 0001824673 · Chief Business Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 132,106 F1 · kind: Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on November 15, 2023. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 that was entered into on January 25, 2024 and the sale does not represent a discretionary trade by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $45.53 to $46.45, inclusive. F4 · balance_after: Includes 116,875 unvested RSUs. Read SEC document |
| August 19, 2024 Filed Aug 20, 2024 20:27 UTC |
McNeill JonathanChief Business Officer
|
SaleCommon Stock | 2,400 | $45.01 | $108,024.00 |
DisclosureSEC source: 0000950170-24-099127 · ownership.xml · nonDerivative · entry 1 McNeill Jonathan · CIK 0001824673 · Chief Business Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 132,411 F1 · kind: Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on November 15, 2023. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 that was entered into on January 25, 2024 and the sale does not represent a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $44.51 to $45.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes of this Form 4. Read SEC document |
| August 19, 2024 Filed Aug 20, 2024 20:27 UTC |
Farwell WildonChief Medical Officer
|
SaleCommon Stock | 261 | $46.00 | $12,006.00 |
DisclosureSEC source: 0000950170-24-099125 · ownership.xml · nonDerivative · entry 2 Farwell Wildon · CIK 0001847941 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 143,222 F1 · kind: Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on November 15, 2023. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 that was entered into on January 25, 2024 and the sale does not represent a discretionary trade by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $45.53 to $46.45, inclusive. F4 · balance_after: Includes 110,408 unvested RSUs. Read SEC document |
| August 19, 2024 Filed Aug 20, 2024 20:27 UTC |
Farwell WildonChief Medical Officer
|
SaleCommon Stock | 2,060 | $45.01 | $92,720.60 |
DisclosureSEC source: 0000950170-24-099125 · ownership.xml · nonDerivative · entry 1 Farwell Wildon · CIK 0001847941 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 143,483 F1 · kind: Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on November 15, 2023. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 that was entered into on January 25, 2024 and the sale does not represent a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $44.51 to $45.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes of this Form 4. Read SEC document |
| August 19, 2024 Filed Aug 20, 2024 20:26 UTC |
HIGH SUSANNA GATTIChief Operating Officer
|
SaleCommon Stock | 328 | $46.00 | $15,088.00 |
DisclosureSEC source: 0000950170-24-099124 · ownership.xml · nonDerivative · entry 2 HIGH SUSANNA GATTI · CIK 0001691005 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 145,882 F1 · kind: Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on November 15, 2023. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 that was entered into on January 25, 2024 and the sale does not represent a discretionary trade by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $45.53 to $46.45, inclusive. F4 · balance_after: Includes 128,699 unvested RSUs. Read SEC document |
| August 19, 2024 Filed Aug 20, 2024 20:26 UTC |
HIGH SUSANNA GATTIChief Operating Officer
|
SaleCommon Stock | 2,582 | $45.01 | $116,215.82 |
DisclosureSEC source: 0000950170-24-099124 · ownership.xml · nonDerivative · entry 1 HIGH SUSANNA GATTI · CIK 0001691005 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 146,210 F1 · kind: Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on November 15, 2023. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 that was entered into on January 25, 2024 and the sale does not represent a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $44.51 to $45.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes of this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.